These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 4660914)
81. [The selective permeability of the alveolar-capillary barrier]. Racoveanu C; Manicatide M Stud Cercet Med Interna; 1972; 13(4):317-33. PubMed ID: 4644117 [No Abstract] [Full Text] [Related]
82. Experimental lead encephalopathy in the suckling rat: concentration of lead in cellular fractions enriched in brain capillaries. Toews AD; Kolber A; Hayward J; Krigman MR; Morell P Brain Res; 1978 May; 147(1):131-8. PubMed ID: 656908 [TBL] [Abstract][Full Text] [Related]
83. Heterogeneity of the capillary flow in the brain. Hertz MM; Paulson OB Acta Neurol Scand Suppl; 1977; 64():488-9. PubMed ID: 268886 [No Abstract] [Full Text] [Related]
84. [Study of the effects of diethylamine carboxylate-2 chromone on capillary permeability. Tests based on dye diffusion]. Conquet P; Plazonnet B; Bonnet P; Tronche P; Bastide P C R Seances Soc Biol Fil; 1970; 164(4):800-4. PubMed ID: 4252149 [No Abstract] [Full Text] [Related]
85. [Behavior of the rabbit circumventricular organsfllowing intravenous administration of trypan blue]. Weindl A Naturwissenschaften; 1967 Jul; 54(13):342. PubMed ID: 5585349 [No Abstract] [Full Text] [Related]
88. Effect of various lead doses on some cerebral capillary functions in the suckling rat. Lefauconnier JM; Lavielle E; Terrien N; Bernard G; Fournier E Toxicol Appl Pharmacol; 1980 Sep; 55(3):467-76. PubMed ID: 7434359 [No Abstract] [Full Text] [Related]
89. Blood-brain barrier dysfunction after amphetamine administration in rats. Carlsson C; Johansson BB Acta Neuropathol; 1978 Feb; 41(2):125-9. PubMed ID: 636843 [No Abstract] [Full Text] [Related]
90. [Capillary permeability and vesicular transport]. Kamiya R Nihon Rinsho; 1982; 40(3):524-9. PubMed ID: 7098017 [No Abstract] [Full Text] [Related]
91. [Influence of electroconvulsions on the permeability of the blood-brain barrier to trypan blue]. da Costa JC Arq Neuropsiquiatr; 1972 Mar; 30(1):1-7. PubMed ID: 5045075 [No Abstract] [Full Text] [Related]
93. [Experimental study of hyaluronidase electrophoresis]. PertsovskiÄ AI; Gol'dman RN; Koval'chuk SI Vopr Kurortol Fizioter Lech Fiz Kult; 1974; (5):404-7. PubMed ID: 4446424 [No Abstract] [Full Text] [Related]
94. The basis for active transport at the blood-brain barrier. Betz AL; Goldstein GW Adv Exp Med Biol; 1980; 131():5-16. PubMed ID: 7001870 [No Abstract] [Full Text] [Related]
95. Drug entry into the brain. Rapoport SI; Ohno K; Pettigrew KD Brain Res; 1979 Aug; 172(2):354-9. PubMed ID: 466480 [No Abstract] [Full Text] [Related]
96. REVERSIBLE BLOOD-BRAIN BARRIER ALTERATION INDUCED BY CERTAIN ORGANIC ACIDS AND INDICATED BY MEANS OF EEG AND DYE TESTS. FLODMARK S; STEINWALL O Acta Physiol Scand; 1963 Aug; 58():368-75. PubMed ID: 14078654 [No Abstract] [Full Text] [Related]
97. The blood-brain barrier: an alternative hypothesis. Lockard I J Theor Biol; 1982 Jul; 97(2):167-76. PubMed ID: 7132390 [No Abstract] [Full Text] [Related]
98. Mechanisms of neuropeptide interaction with the blood-brain barrier. Pardridge WM Ann N Y Acad Sci; 1986; 481():231-49. PubMed ID: 3028231 [No Abstract] [Full Text] [Related]
99. Effect of adrenochrome on spreading action of hyaluronidase and capillary permeability. CLARK WG Exp Med Surg; 1949; 7(2-3):78-85. PubMed ID: 18151277 [No Abstract] [Full Text] [Related]
100. Factors which determine cerebrovascular permeability in the normal brain and following osmotic treatment. Rapoport SI Adv Exp Med Biol; 1980; 131():179-92. PubMed ID: 7001868 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]